BlackRock Portfolio holdings
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$2.71B |
| 2 |
Alibaba
BABA
|
+$2.19B |
| 3 |
Truist Financial
TFC
|
+$2.16B |
| 4 |
iShares MBS ETF
MBB
|
+$841M |
| 5 |
ServiceNow
NOW
|
+$829M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$5.15B |
| 2 |
STI
SunTrust Banks, Inc.
STI
|
+$2.34B |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$983M |
| 4 |
VIAB
Viacom Inc. Class B
VIAB
|
+$684M |
| 5 |
Apple
AAPL
|
+$623M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.19% |
| 2 | Financials | 14.42% |
| 3 | Healthcare | 13.59% |
| 4 | Consumer Discretionary | 9.97% |
| 5 | Industrials | 9.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3376
Hawthorn Bancshares
HWBK
$278M
| $7.4M | ﹤0.01% |
339,588
+3,869
| +1% | +$80.1K |
|
3377
Ascent Industries
ACNT
$141M
| $7.4M | ﹤0.01% |
572,937
+2,907
| +0.5% | +$40.4K |
|
3378
Galectin Therapeutics
GALT
$348M
| $7.39M | ﹤0.01% |
2,583,131
+286,206
| +12% | +$995K |
|
3379
CALL
Viatris
VTRS
$18.9B
| $7.38M | ﹤0.01% |
367,000
-28,500
| -7% | -$530K |
|
3380
iShares North American Natural Resources ETF
IGE
$754M
| $7.35M | ﹤0.01% |
244,244
| – | – |
|
3381
Novavax
NVAX
$1.31B
| $7.34M | ﹤0.01% |
1,844,567
-33,068
| -2% | -$143K |
|
3382
CALL
Freeport-McMoran
FCX
$97.5B
| $7.33M | ﹤0.01% |
+558,500
| New | +$6.13M |
|
|
FM
3383
DELISTED
iShares Frontier and Select EM ETF
FM
| $7.32M | ﹤0.01% |
241,268
+1,210
| +0.5% | +$35K |
|
3384
iShares MSCI KLD 400 Social ETF
DSI
$5.54B
| $7.27M | ﹤0.01% |
121,054
+112,602
| +1,332% | +$6.47M |
|
3385
Spero Therapeutics
SPRO
$73M
| $7.26M | ﹤0.01% |
755,265
+76,316
| +11% | +$823K |
|
|
ASRT
3386
DELISTED
Assertio
ASRT
| $7.25M | ﹤0.01% |
96,624
-107,165
| -53% | -$6.28M |
|
|
BBL
3387
DELISTED
BHP Group Plc American Depositary Shares (Each representing two Ordinary Shares)
BBL
| $7.2M | ﹤0.01% |
153,250
-44,335
| -22% | -$1.95M |
|
|
VIE
3388
DELISTED
Viela Bio, Inc. Common Stock
VIE
| $7.18M | ﹤0.01% |
+264,617
| New | +$6.67M |
|
3389
EVI Industries
EVI
$180M
| $7.15M | ﹤0.01% |
264,314
+413
| +0.2% | +$12.9K |
|
3390
Sutro Biopharma
STRO
$421M
| $7.12M | ﹤0.01% |
64,711
+309
| +0.5% | +$31.9K |
|
|
RFP
3391
DELISTED
Resolute Forest Products Inc.
RFP
| $7.11M | ﹤0.01% |
1,691,788
-142,289
| -8% | -$591K |
|
|
FLG.PRU
3392
Flagstar Bank National Association Bifurcated Option Note Unit Securities
FLG.PRU
$118M
| $7.08M | ﹤0.01% |
139,697
+19,288
| +16% | +$975K |
|
3393
Coastal Financial
CCB
$693M
| $7.06M | ﹤0.01% |
428,597
+12,390
| +3% | +$200K |
|
3394
Ponce Financial Group
PDLB
$485M
| $7.02M | ﹤0.01% |
666,111
+5,235
| +0.8% | +$53.3K |
|
3395
Globalstar
GSAT
$10.8B
| $7.02M | ﹤0.01% |
902,137
+7,283
| +0.8% | +$44K |
|
3396
iShares MSCI Brazil ETF
EWZ
$8.95B
| $7.02M | ﹤0.01% |
147,848
-1,396,993
| -90% | -$61.2M |
|
|
LEVL
3397
DELISTED
Level One Bancorp, Inc. Common Stock
LEVL
| $6.99M | ﹤0.01% |
277,817
+2,005
| +0.7% | +$49.2K |
|
3398
Avalo Therapeutics
AVTX
$983M
| $6.97M | ﹤0.01% |
449
+14
| +3% | +$148K |
|
|
PBPB
3399
DELISTED
Potbelly
PBPB
| $6.96M | ﹤0.01% |
1,649,877
-4,102
| -0.2% | -$17.9K |
|
3400
Vanguard Morningstar Growth ETF
VUG
$230B
| $6.91M | ﹤0.01% |
227,718
-492
| -0.2% | -$14.2K |
|
Similar funds
BlackRock's Q4 2019 Portfolio in Review
As of Q4 2019, BlackRock held 5,193 positions worth $2.61T, up 9.5% from $2.38T the previous quarter. Its ten largest holdings account for 15% of the portfolio.
BlackRock's Q4 2019 filing shows 167 new, 2,887 increased, 1,450 reduced and 161 closed positions. Its largest new stake was Broadcom Inc. 8.00% Mandatory Convertible Preferred Stock, Series A: 324,030 shares worth $382M. The largest sale was Celgene Corp, an estimated $5.15B.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.
- BlackRock's largest Q4 2019 buy was Broadcom Inc. 8.00% Mandatory Convertible Preferred Stock, Series A: 324,030 shares worth $382M.
- BlackRock added most to Bristol-Myers Squibb in Q4 2019, an estimated $2.71B increase.
- BlackRock's biggest Q4 2019 reduction was iShares Core S&P 500 ETF, cutting an estimated $983M.
- BlackRock fully exited Celgene Corp in Q4 2019, selling an estimated $5.15B.
- BlackRock's ten largest holdings make up 15% of its $2.61T portfolio in Q4 2019.
- BlackRock opened 167 new positions and closed 161 in Q4 2019.
- BlackRock's portfolio value rose 9.5% quarter-over-quarter to $2.61T.
Based on BlackRock's 13F filing for Q4 2019, filed 13 Feb 2020.